Tag: Bharat Biotech

New Delhi: Increasing efforts towards faster mass vaccination and virus surveillance is the key to ward off dangers posed by a triple-mutant coronavirus now present in the country, health experts…

New Delhi: Looking to ramp up supplies ahead of the opening of Covid-19 vaccination to all citizens over 18 years of age, the government has approved a payment of about…

New Delhi: The Indian Council of Medical Research (ICMR) on Saturday partnered with Bharat Biotech International Limited (BBIL) to develop a fully indigenous vaccine for coronavirus. According to a statement issued by the ICMR, the team will use the virus strain isolated at ICMR’s National Institute of Virology (NIV) in Pune. “The strain has been […]

Hyderabad: Bharat Biotech, has successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous, inactivated vaccine developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level […]

Chandigarh: The human trial of Bharat Biotech’s anti-COVID-19 vaccine Covaxin began at Rohtak’s Post-Graduate Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij tweeted. In his tweet, the minister also said the vaccine has been administered to three persons who have shown no adverse effect to it. “Human trial with Corona vaccine (COVAXIN) […]

New Delhi: At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already infected more than 14 million globally. Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological […]

Hyderabad: The stage is set for phase II clinical trials of Bharat Biotech’s coronavirus vaccine from Monday. The Hyderabad-based vaccine maker received the approval from Central Drugs Standard Control Organisation under the Directorate General of Health Services to conduct the phase II trials of indigenous vaccine candidate Covaxin. Joint Drugs Controller Dr S. Eswara Reddy […]

Hyderabad: Vaccine maker Bharat Biotech on Friday announced that the animal trials of its Covid-19 vaccine candidate Covaxin were successful. It said the results demonstrated the protective efficacy of the vaccine in a live viral challenge model. “Bharat Biotech proudly announces the animal study results of COVAXIN – These results demonstrate the protective efficacy in […]

Hyderabad: Leading vaccine maker Bharat Biotech on Wednesday announced a licensing agreement with Washington University School of Medicine in St. Louis for a novel chimp-adenovirus, single dose intranasal vaccine for Covid-19. The Hyderabad-based company owns the rights to distribute the vaccine in all markets except USA, Japan and Europe. While the Phase I trials will […]

New Delhi: Union Health Minister Harsh Vardhan on Sunday informed that Bharat Biotech will develop an intranasal vaccine for Sars-CoV-2, the virus that causes Covid-19. The minister said that the Hyderabad-based drugs and vaccine research and manufacturing company has entered into an agreement with Washington University and St. Louis University for the trials of the […]

Bhubaneswar: The third and final phase of the ongoing clinical trials of Covaxin – India’s indigenous Covid-19 vaccine candidate will shortly begin in Odisha. The Phase III trials of Covaxin will be conducted at 21 centres across India and at SUM hospital in Odisha (Bhubaneswar). The vaccine will be administered to nearly 2,000 volunteers in […]

Hyderabad: Bharat Biotech, which recently received approval to conduct Phase III human trials of India’s first indigenous coronavirus vaccine, Covaxin, has said that the vaccine has been found to be safe without any major adverse events in the first two stages of trials and that its goal is to attain strong immune response rate in […]

Bhubaneswar: With scientists across the world working overtime to prepare a vaccine for Covid-19 by the year end, it is expected that the vaccine could be introduced in India as early as February,2021. Speculations became rife after Bharat Biotech’s Covid-19 vaccine candidate showed safety and efficacy during the phase 1 and 2 trials as well […]

Hyderabad: Bharat Biotech on Monday raised the logistical query on “how to vaccinate 1.3 billion (130 crore) people with two injectable doses of India’s first indigenous coronavirus vaccine Covaxin”. Terming the exercise a “challenge” it also said that work was on single-dose nasal drop vaccine. Bharat Biotech’s comment comes while Covaxin is entering its third […]

Hyderabad: Phase-3 trials of Covaxin, India’s first indigenous vaccine for Covid-19 commenced today, vaccine maker Bharat Biotech announced on Monday. The Phase-3 trials, which involve 26,000 volunteers across India, are being conducted in partnership with the Indian Council of Medical Research (ICMR). This is India’s first Phase-3 efficacy study for a Covid-19 vaccine, and the […]